Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD

• Published in: Eye (London) Vol. 35; no. 11; pp. 2983 - 2990
• Main Authors: Chakravarthy, Usha, Havilio, Moshe, Syntosi, Annie, Pillai, Natasha, Wilkes, Emily, Benyamini, Gidi, Best, Catherine, Sagkriotis, Alexandros
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.11.2021; Nature Publishing Group
• Subjects: 692/308/409; 692/308/53/2422; 692/53/2422; 692/699/3161/1626; Acuity; Age; Algorithms; Angiogenesis Inhibitors - therapeutic use; Artificial Intelligence; Automation; Bevacizumab - therapeutic use; Diabetic retinopathy; Electronic medical records; Exports; Eye; Humans; Intravitreal Injections; Laboratory Medicine; Macular degeneration; Medical records; Medicine; Medicine & Public Health; Ophthalmology; Pharmaceutical Sciences/Technology; Ranibizumab - therapeutic use; Retina; Software; Standard deviation; Subretinal Fluid; Surgery; Surgical Oncology; Tomography, Optical Coherence; Treatment Outcome; Vascular endothelial growth factor; Visual Acuity; Wet Macular Degeneration - drug therapy
• ISSN: 0950-222X; 1476-5454
• DOI: 10.1038/s41433-020-01354-4

Objectives To study the effect of repeated retinal thickness fluctuations during the anti-VEGF therapy maintenance phase in neovascular age-related macular degeneration (nAMD). Methods Data were extracted from electronic medical records of 381 nAMD patients, aged ≥50 years; baseline VA ≥33 and ≤73 letters; ≥24 months’ follow-up and ≥2 optical coherence tomography (OCT) measurements. OCT scans were analysed using an artificial intelligence algorithm that quantified the volumes of intraretinal fluid (IRF), subretinal fluid (SRF), pigment epithelial detachments (PED) and central subfield thickness (CSFT). IRF, SRF and PED were summed to obtain total fluid (TF). The standard deviation (SD) of IRF, SRF, PED, CSFT and TF was computed and categorised into quartiles (SD-Q). Relationships between SD-Qs for each OCT feature and VA change was tested using generalised estimating equations and linear regression. Results By Month 24, compared to SD-Q1, eyes in SD-Q2, SD-Q3, and SD-Q4 for IRF, SRF, PED, CSFT and TF showed greater VA losses. Eyes in SD-Q4 of TF were 9.4 letters worse compared to eyes in Q1 (95% Confidence Interval: −12.9 to −6.0). The frequency of clinic visits with IRF and SRF present on OCT scans by quartiles of CSFT was lower in eyes with least fluctuation (Q1) compared to eyes with the most fluid fluctuation (Q4) (median [IQR] IRF: 0.3 [0.0–0.7] versus 0.8 [0.5–1.0]; SRF: 0.0 [0.0–0.5] versus 0.6 [0.3–1.0]). Conclusions Greater fluctuations in retinal fluid volumes during the maintenance phase of anti-VEGF treatment in nAMD is associated with worse VA by 2 years.